Using a panel of CRC cell lines, we demonstrated that cells expressing PAI1 are sensitive to Pim inhibitor AZD1208, suggesting that PAI1 expression could be used as a potential marker effectiveness to treatment with Pim inhibitors after radiotherapy. The gene discussed is PIM1; the disease is colorectal carcinoma.